Trial Details
UNKNOWNBasic Information
| Clinical ID | c746 |
|---|---|
| Identifier | NCT04919252 |
| Trial Title | Efficacy and Safety of Vedolizumab in Biologic-naive Korean Patients With Moderate to Severe Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease and Ulcerative Colitis |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | Yonsei University |
|---|---|
| City | Seoul |
| Country/Region | Korea, Republic of |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-06-01 |
|---|---|
| Primary Completion Date | 2022-12-31 |
| Completion Date | 2023-01-31 |